MJB
ABMD

Mark J. Bradley’s Abiomed Inc ABMD Stock Holding History

Mark J. Bradley’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,375
Closed -$2.3M – 47
2022
Q3 		$2.3M Buy
9,375
+50
+0.5% +$13.5K 2.13% 24
2022
Q2 		$2.31M Sell
9,325
-50
-0.5% -$13.5K 2.09% 20
2022
Q1 		$3.11M Buy
9,375
+90
+1% +$27.7K 2.21% 19
2021
Q4 		$3.33M Sell
9,285
-115
-1% -$38.9K 2.18% 23
2021
Q3 		$3.06M Sell
9,400
-150
-2% -$50.8K 2.09% 24
2021
Q2 		$2.98M Sell
9,550
-185
-2% -$56.8K 1.99% 25
2021
Q1 		$3.1M Sell
9,735
-380
-4% -$122K 2.1% 22
2020
Q4 		$3.28M Buy
+10,115
New +$2.8M 2.26% 16

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mark J. Bradley's ABMD Position: Q4 2022 in Review

Mark J. Bradley sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 9,375 shares — an estimated $2.3M sold.

Mark J. Bradley first reported a position in ABMD in Q4 2020 and held it in 8 quarters. The position peaked at $3.33M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Mark J. Bradley reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Mark J. Bradley sold 9,375 Abiomed Inc shares in Q4 2022, an estimated $2.3M.
  • Mark J. Bradley first reported a position in Abiomed Inc in Q4 2020 and held it in 8 quarters.
  • Mark J. Bradley's Abiomed Inc position peaked at $3.33M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Mark J. Bradley's 13F filing for Q4 2022, filed 15 Feb 2023.